title: On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease.
abstract: Nitrite and nitrate are frequently used surrogate markers of nitric oxide (NO) production. Using rat models of acute and chronic DSS-induced colitis we examined the applicability of these and other NO-related metabolites, in tissues and blood, for the characterization of inflammatory bowel disease. Global NO dynamics were assessed by simultaneous quantification of nitrite, nitrate, nitroso and nitrosyl species over time in multiple compartments. NO metabolite levels were compared to a composite disease activity index (DAI) and contrasted with measurements of platelet aggregability, ascorbate redox status and the effects of 5-aminosalicylic acid (5-ASA). Nitroso products in the colon and in other organs responded in a manner consistent with the DAI. In contrast, nitrite and nitrate, in both intra- and extravascular compartments, exhibited variations that were not always in step with the DAI. Extravascular nitrite, in particular, demonstrated significant temporal instabilities, ranging from systemic drops to marked increases. The latter was particularly evident after cessation of the inflammatory stimulus and accompanied by profound ascorbate oxidation. Treatment with 5-ASA effectively reversed these fluctuations and the associated oxidative and nitrosative stress. Platelet activation was enhanced in both the acute and chronic model. Our results offer a first glimpse into the systemic nature of DSS-induced inflammation and reveal a greater complexity of NO metabolism than previously envisioned, with a clear dissociation of nitrite from other markers of NO production. The remarkable effectiveness of 5-ASA to abrogate the observed pattern of nitrite instability suggests a hitherto unrecognized role of this molecule in either development or resolution of inflammation. Its possible link to tissue oxygen consumption and the hypoxia that tends to accompany the inflammatory process warrants further investigation.
authors.affiliation: Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA 02118, USA.
authors.forename: Fumito
authors.initials: F
authors.lastname: Saijo
authors.forename: Alexandra B
authors.initials: AB
authors.lastname: Milsom
authors.forename: Nathan S
authors.initials: NS
authors.lastname: Bryan
authors.forename: Selena M
authors.initials: SM
authors.lastname: Bauer
authors.forename: Thorsten
authors.initials: T
authors.lastname: Vowinkel
authors.forename: Marina
authors.initials: M
authors.lastname: Ivanovic
authors.forename: Chris
authors.initials: C
authors.lastname: Andry
authors.forename: D Neil
authors.initials: DN
authors.lastname: Granger
authors.forename: Juan
authors.initials: J
authors.lastname: Rodriguez
authors.forename: Martin
authors.initials: M
authors.lastname: Feelisch
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D004195:Disease Models, Animal; D015212:Inflammatory Bowel Diseases / Q000378:metabolism*; D008297:Male; D019804:Mesalamine / Q000378:metabolism; D009566:Nitrates / Q000378:metabolism*; D009569:Nitric Oxide / Q000096:biosynthesis*; D009573:Nitrites / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D015415:Biomarkers; D009566:Nitrates; D009573:Nitrites; D009569:Nitric Oxide; D019804:Mesalamine